- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 211.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 220.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 212.05M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.44M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $342.75M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $344.2M |
| Capex | Q1 2026 · Mar 31, 2026 | $12.36M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $117.08M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $489.86M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $481.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $138.99M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $138.92M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $119.56M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $138.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.33B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.43B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.89B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $14.94B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $29.1B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $29.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.14 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.28 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.28 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.51M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $45.97M |
| Net Income | Q1 2026 · Mar 31, 2026 | $240.98M |
| Net Income | Q1 2026 · Mar 31, 2025 | $270.88M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $367.55M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $388.73M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $238.3M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $223.58M |
| Revenue | Q1 2026 · Mar 31, 2026 | $33.7M |
| Revenue | Q1 2026 · Mar 31, 2025 | $30.91M |